本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aerovate Therapeutics, Inc.

9.80
+0.0000
成交量:- -
成交额:- -
市值:2.84亿
市盈率:-5.76
高:9.80
开:9.80
低:9.80
收:9.80
数据加载中...
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/31

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/10/31

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/10/31

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/10/31

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/10/31

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/10/31

重要事件披露

Form 8-K - Current report
2024/10/17

重要事件披露

Form 8-K - Current report
2024/10/10

重要事件披露

Form 8-K - Current report
2024/08/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/08

重要事件披露

Form 8-K - Current report
2024/07/01

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/06/28

重要事件披露

Form 8-K - Current report
2024/06/20

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/17

重要事件披露

Form 8-K - Current report
2024/06/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities